Day: October 29, 2025

Oxford, UK – 29 October 2025: OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has been recognised as a Champion in the ‘Cell & Gene Therapy’ category at the 2025 CDMO Leadership Awards Europe in Frankfurt. The prestigious Champion title is awarded to the highest-scoring CDMO in each category, based on direct feedback from biopharmaceutical professionals who have recently partnered with CDMOs. This recognition demonstrates OXB’s excellence in quality, innovation and service across its global network. It comes at a time of strong commercial momentum for OXB, driven by increased demand for its end-to-end CDMO services across key vector types and a growing portfolio of clients spanning all stages of development. Dr. Sebastien Ribault, Chief Business Officer of OXB, said: “We are honoured...

New York, NY, Oct. 29, 2025 (GLOBE NEWSWIRE) — Trailblazer Acquisition Corp. (Nasdaq: BLZRU) (the “Company”) announced today that, commencing October 31, 2025, holders of the units sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares and warrants included in the units. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The Class A ordinary shares and warrants that are separated will trade on the Nasdaq Global Market under the symbols “BLZR” and “BLZRW,” respectively. Those units not separated will continue to trade on the Nasdaq Global Market under the symbol “BLZRU.” This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any...

WUXI, China, Oct. 29, 2025 (GLOBE NEWSWIRE) — LOBO Technologies Ltd. (NASDAQ: LOBO), a developer and manufacturer of electric mobility and smart energy solutions, today announced that it has received a bulk purchase order valued at approximately US$1.194 million from Terrian Town Limited, a Kenyan real estate company, for its advanced Photovoltaic power storage systems. The systems, which include 10kW photovoltaic arrays paired with 20kWh lithium iron phosphate (LiFePO4) batteries, are designed to support up to 80% of the power demand for the residential units. The order covers 80 villas at an estimated cost of US$ 13.9K per household, as well as portions of the business units within the development. The total order value is at approximately US$1.194 million. Terrian Town owns 8.62 hectares in the Kajiado of Kenya. Management intends...

Only one new luxury home remains available for sale CUMMING, Ga., Oct. 29, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, announced the final opportunity to purchase a new home at its Brookmeade Trail community, an elegant enclave by Toll Brothers in Cumming, Georgia. The final luxury home in the community is now available for purchase, marking the last chance for home shoppers to purchase a new home in this exceptional neighborhood. Brookmeade Trail is nestled in a serene setting featuring spacious single-family homes. The final remaining home, featuring the Rosewater Transitional home design, embodies the community’s commitment to luxury with its expansive, 4,500-square-foot open-concept floor plan including 5 bedrooms, 5.5 baths, elegant finishes, outdoor living spaces,...

New data reinforce rosnilimab’s efficacy profile in rheumatoid arthritis (RA) with deepening of clinical responses, including CDAI remission, from Week 12 to Week 28 regardless of prior advanced therapy, including JAKs New data confirm durable clinical benefit across multiple higher-order response measures, including CDAI LDA and DAS28 LDA, after Week 28 for at least three months off drug Updated safety data through Week 38 demonstrate rosnilimab was well-tolerated with no treatment-related serious adverse events and no malignancies in rosnilimab-treated patientsSAN DIEGO, Oct. 29, 2025 (GLOBE NEWSWIRE) — AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced late-breaking data from the robust, global 424-patient Phase 2b trial of rosnilimab,...

SAN JUAN, Puerto Rico, Oct. 29, 2025 (GLOBE NEWSWIRE) — Red Cat Holdings, Inc. (Nasdaq: RCAT) (“Red Cat” or the “Company”), a U.S.-based provider of advanced all-domain drone and robotic solutions for defense and national security, today announced that Stan Nowak, Vice President of Marketing, will present at the ThinkEquity Conference at 3:00 p.m. Eastern Standard Time on Thursday, October 30, 2025 at the Mandarin Oriental Hotel in New York, NY. A webcast of Red Cat’s presentation will be available here and on the Company’s Investor Relations website at ir.redcatholdings.com. Investors interested in scheduling meetings with Red Cat should contact their conference representative or the Red Cat investor relations team. More information about the ThinkEquity Conference, including registration information, can be found...

SAN FRANCISCO and BOSTON, Oct. 29, 2025 (GLOBE NEWSWIRE) — MapLight Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders, today announced the closing of its initial public offering of 16,962,500 shares of common stock at an initial public offering price of $17.00 per share, which includes the exercise in full by the underwriters of their option to purchase an additional 2,212,500 shares of common stock. In addition to the shares sold in the initial public offering, MapLight announced the closing of the concurrent sale of 476,707 shares of common stock at the initial public offering price per share in a private placement to affiliates of Goldman Sachs & Co. LLC, including certain investment funds managed by Goldman...